scispace - formally typeset
M

Margreet A. Wolfert

Researcher at University of Georgia

Publications -  69
Citations -  7079

Margreet A. Wolfert is an academic researcher from University of Georgia. The author has contributed to research in topics: Lipid A & Antigen. The author has an hindex of 41, co-authored 67 publications receiving 6493 citations. Previous affiliations of Margreet A. Wolfert include Utrecht University & University of Birmingham.

Papers
More filters
Journal ArticleDOI

Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions.

TL;DR: Azides, which are extremely rare in biological systems, are emerging as attractive chemical handles for bioconjugation and have been employed for the tagging of a variety of biomolecules, activity-based protein profiling, and the chemical synthesis of microarrays and small molecule libraries.
Journal ArticleDOI

Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery.

TL;DR: It is proposed that rapid plasma elimination of polycation/DNA complexes results from their binding serum albumin and other proteins, perhaps due to aggregation and phagocytic capture or accumulation of the ternary complexes in fine capillary beds.
Journal ArticleDOI

Characterization of Vectors for Gene Therapy Formed by Self-Assembly of DNA with Synthetic Block Co-Polymers

TL;DR: A-B type cationic-hydrophilic block co-polymers are used to introduce a protective surface hydrophilic shielding following oriented self-assembly with DNA to permit design of materials for specific applications, including targeted delivery of genes in vivo.
Journal ArticleDOI

Selective Labeling of Living Cells by a Photo-Triggered Click Reaction

TL;DR: The cyclopropenone-based phototriggered click chemistry offers exciting opportunities to label living organisms in a temporally and spatially controlled manner and may facilitate the preparation of microarrays.
Journal ArticleDOI

Robust immune responses elicited by a fully synthetic three-component vaccine

TL;DR: It is found that a three-component vaccine composed of a TLR2 agonist, a promiscuous peptide T-helper epitope and a tumor- associated glycopeptide can elicit in mice exceptionally high titers of IgG antibodies that can recognize cancer cells expressing the tumor-associated carbohydrate.